GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Precision BioSciences Inc (FRA:PBS0) » Definitions » Gross Profit

Precision BioSciences (FRA:PBS0) Gross Profit : €53.19 Mil (TTM As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Precision BioSciences Gross Profit?

Precision BioSciences's gross profit for the three months ended in Mar. 2024 was €16.18 Mil. Precision BioSciences's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was €53.19 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Precision BioSciences's gross profit for the three months ended in Mar. 2024 was €16.18 Mil. Precision BioSciences's Revenue for the three months ended in Mar. 2024 was €16.18 Mil. Therefore, Precision BioSciences's Gross Margin % for the quarter that ended in Mar. 2024 was N/A%.

Precision BioSciences had a gross margin of N/A% for the quarter that ended in Mar. 2024 => No sustainable competitive advantage


Precision BioSciences Gross Profit Historical Data

The historical data trend for Precision BioSciences's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Precision BioSciences Gross Profit Chart

Precision BioSciences Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial 20.01 19.96 102.24 23.69 44.68

Precision BioSciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.20 18.27 12.29 6.45 16.18

Competitive Comparison of Precision BioSciences's Gross Profit

For the Biotechnology subindustry, Precision BioSciences's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Precision BioSciences's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Precision BioSciences's Gross Profit distribution charts can be found below:

* The bar in red indicates where Precision BioSciences's Gross Profit falls into.



Precision BioSciences Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Precision BioSciences's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=44.683 - 0
=44.68

Precision BioSciences's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=16.177 - 0
=16.18

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €53.19 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Precision BioSciences's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=16.18 / 16.177
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Precision BioSciences  (FRA:PBS0) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Precision BioSciences had a gross margin of N/A% for the quarter that ended in Mar. 2024 => No sustainable competitive advantage


Precision BioSciences Gross Profit Related Terms

Thank you for viewing the detailed overview of Precision BioSciences's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Precision BioSciences (FRA:PBS0) Business Description

Traded in Other Exchanges
Address
302 East Pettigrew Street, Dibrell Building, Suite A-100, Durham, NC, USA, 27701
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

Precision BioSciences (FRA:PBS0) Headlines

No Headlines